Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
ChemMedChem ; 18(6): e202200632, 2023 03 14.
Article in English | MEDLINE | ID: mdl-36710259

ABSTRACT

Two series of macrocyclic plasmin inhibitors with a C-terminal benzylamine group were synthesized. The substitution of the N-terminal phenylsulfonyl group of a previously described inhibitor provided two analogues with sub-nanomolar inhibition constants. Both compounds possess a high selectivity against all other tested trypsin-like serine proteases. Furthermore, a new approach was used to selectively introduce asymmetric linker segments. Two of these compounds inhibit plasmin with Ki values close to 2 nM. For the first time, four crystal structures of these macrocyclic inhibitors could be determined in complex with a Ser195Ala microplasmin mutant. The macrocyclic core segment of the inhibitors binds to the open active site of plasmin without any steric hindrance. This binding mode is incompatible with other trypsin-like serine proteases containing a sterically demanding 99-hairpin loop. The crystal structures obtained experimentally explain the excellent selectivity of this inhibitor type as previously hypothesized.


Subject(s)
Antifibrinolytic Agents , Fibrinolysin , Fibrinolysin/chemistry , Fibrinolysin/metabolism , Antifibrinolytic Agents/chemistry , Antifibrinolytic Agents/pharmacology , Trypsin/chemistry , Protein Binding , Serine Proteinase Inhibitors/pharmacology , Serine Proteinase Inhibitors/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL